✳flâneur — a map of the web's best reading

RetinaToday | Changing Clinical Paradigm in Diabetic Retinopathy

supplements.retinatoday.com · 906 words · saved by 1 readers

Thanks for visiting RetinaToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to avoid adverse performance issues with this site, please white list https://supplements.retinatoday.com in your ad blocker then refresh this page. Need help? Click here for instructions. © 2024 Bryn Mawr Communications, LLC.All Rights Reserved | Privacy Policy Changing Clinical Paradigm in Diabetic Retinopathy A New Horizon in ROP: The RAINBOW Study Clinical Perspectives on Ranibizumab as a Therapy for All Ages PREVIOUS ARTICLE: Closing Comments Adrian Koh Diabetes is a growing worldwide epidemic, affecting the working age population. The number of individuals affected with diabetes is expected to increase by around 48% between 2017 and 2045.9 A common microvascular complication of diabetes, diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in the developed world.10,11 The advanced, visio

Diabetes is a growing worldwide epidemic, affecting the working age population. The number of individuals affected with diabetes is expected to increase by around 48% between 2017 and 2045. 9 A common microvascular complication of diabetes, diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in the developed world. 10,11 The advanced, vision-threatening stages of DR are proliferative DR (PDR) and diabetic macular edema (DME). 10,11 In clinical trials of DR, the Early Treatment Diabetic Retinopathy Study (ETDRS) DR severity scale (DRSS) is used to grade the stage o

Explore this link on the map →

saved by

related reading